Check category
| starley pharma held the 2018 annual work summary meeting
- Categories:Company news
- Author:A SAN wei
- Origin:
- Time of issue:2019-01-25
- Views:0
(Summary description)On the morning of January 25, 2019, Stellaripharma held its annual work summary meeting for 2018. This meeting not only invited all the staff of Zhejiang Sital and relevant leaders of each region, but
| starley pharma held the 2018 annual work summary meeting
(Summary description)On the morning of January 25, 2019, Stellaripharma held its annual work summary meeting for 2018. This meeting not only invited all the staff of Zhejiang Sital and relevant leaders of each region, but
- Categories:Company news
- Author:A SAN wei
- Origin:
- Time of issue:2019-01-25
- Views:0
Information
On the morning of January 25, 2019, Stellaripharma held its annual work summary meeting for 2018. This meeting not only invited all the staff of Zhejiang Sital and relevant leaders of each region, but also invited more than 20 partners from all over the country.
At the meeting, Hu Jian, vice chairman and general manager, announced the decision on Recognizing 2018 Annual Outstanding Performance Workers and commended the 2018 annual Outstanding Performance Advanced departments and workers.
Representative of outstanding performance management cadre, representative of outstanding performance employee and leaders of each territory made a statement one after another.
At the conference, Woo Kam-sang, chairman of The board of Directors, thanked the invited guests for their continuous support and assistance to the development of Sri. At the same time, to distribute in Zhejiang, Jiangxi, Shanghai, Posen, Jianghe, Ireland nearly 1500 employees to express New Year's greetings, but also to the staff who still stick to their posts during the festival to express cordial sympathy.
After 22 years of growth, 2018 has been the year with the best performance in Its history, woo said, thanks to the combined efforts of all its employees. In the complex and volatile economic situation, in 2018, Stellerpharma not only achieved the best performance in history, but also acquired Poseidon Pharmaceuticals, which is a great event to be proud of. How do we operate in the capital markets when We are almost three years from going public? How to promote enterprise reform? How to innovate management? How to achieve high quality rapid development? These are issues worth pondering.
According to Woo, in 2019, we need to comprehensively promote information-based management, using information-based management to carry out detailed calculation and ensure smooth operation of enterprises. On September 15, 2018, After Zhejiang Sintaili moved to the new building, it carried out the internal institutional control again. Only by perfecting the system construction can we do a good job in the fine management of each work. The current OEC system is an important means of information management and control. In order to realize the innovation of organizational structure and management mode, the DIVISION committee and the R&D team of Sidi company should effectively integrate the overall resources. In the future, we should vigorously promote management mode innovation, relying on information and intelligent means to achieve fine control, management mode innovation.
Woo Kam-Sen stressed that we need to keep our eyes inwards and push forward technological re-innovation. The r&d team of Sidi company should strengthen innovation and improve management, so as to achieve the ultimate in our products, quality and cost. Products can be recognized by customers, is our pursuit of the goal, product quality is our lifeline, all staff to work together, the enterprise production, management, control to the extreme, to ensure that the quality of products by customers, the community, the government's recognition. Only after achieving this point, then to achieve economic benefits. So we have to keep our eyes on the inside, improve our technical management methods, and then participate in the market competition. How to achieve technical process innovation again, need high quality, high level of talent to operate. Therefore, the technological innovation of four local companies is the top priority.
Finally, I hope that our stacy people can contribute to the cause of human health, human life, human health into old age rather than death from disease! All the staff should do a good job, do a good job, to create a hundred years of taili and struggle, let taili more beautiful tomorrow! Finally, I wish you a happy New Year and a happy family!

Scan the QR code to read on your phone
Product
News
Research
Responsibility

Wap

Copyright © 2019 Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved. 浙ICP备18046522号